Department of Labor filing
Spot something wrong?GENESIS EGG DONOR AND SURROGACY
GENESIS EGG DONOR AND SURROGACY GROUP 401(K) PLAN · For the plan year ended Dec 31, 2025
Public filing 2025 · received Jun 28, 2026Verified current terms Not available
Plan summary
The numbers that matter first
80Excellent plan health
medium confidence
medium confidence
See what drives the plan health score
Published only when at least four measures and half of the model weight are available. Missing information is excluded rather than scored as zero.
A current plan document is needed to verify the formula.
Not reported was reported per active participant, but this is not a match limit.
A dated plan document is needed.
Plan-paid administrative cost per participant; fund and employee fees may be separate.
The public filing does not provide a current, complete fund menu.
A current plan document is needed.
The selected official filing does not establish a current default rate.
The reviewed official source does not establish current Roth availability.
Not reported per active participant in 2025.
Participation up 0.0% · assets up 0.0% · loans 0.5% of assets
How the score works →What this tells you: company-wide scale, reported employer support, participation activity, visible administrative cost, and historical direction.
Keep in mind: public filings do not show employee investment returns. Scores use only available measures; missing information lowers confidence, never the score. Current match, vesting, eligibility, investments, and employee-paid fees still require a current plan document.
Filing comparison · 2025—There is not enough comparable filing data to calculate this yet.
How this filing compares
Reported employer contributionsNot enough dataTypical peer $2,475 · based on 85,770 comparable plans
Lower reported administrative expense91st percentileTypical peer $102 · based on 77,997 comparable plans
This comparison uses historical filing figures. It does not compare current match formulas, vesting, investments, or employee fees.
Peer-group method: industry size. Limitations: employer_contribution_measure_unavailable
The short version
What employees should know
For the year ended Dec 31, 2025, GENESIS EGG DONOR AND SURROGACY reported Not reported in employer contributions across this plan, or Not reported per active participant. This is the best company-wide filing average available—not a promise of what any one employee receives.
Up 0.0% across the filing years shown. The filing does not report every employee who was eligible.
Change in employer contributions per active participant.
Change in reported administrative cost per participant. Fund expenses may be separate.
A fair peer score is not available yet.
What this public record cannot answer
For the current match, vesting rules, eligibility, employee fees, and investment choices, we need a recent plan document. We leave those details blank until we have one.
Money and scale
Contributions, assets, and expenses
These are plan-wide totals. They are not individual account balances.
- Employer contributions
- Not reported Not reported per active participant
- Participant contributions
- $28,694
- Other contributions
- Not reported Amounts not classified as employer or participant contributions
- Employer share of contributions
- Not reported
- Active participants
- 31 Small plan
- Total participants
- 41 38 at the beginning of the year
- Ending assets
- $231,466 $5,646 per participant
- Net-asset change
- Up 0.0% Not the same as investment performance
- Beginning net assets
- $174,150
- Ending net assets
- $231,466
- Beginning liabilities
- Not reported
- Ending liabilities
- Not reported
- Total income
- $61,796
- Total expenses
- $4,480
- Administrative expenses
- $290 $7 per active participant
- Participant loans
- $1,254 0.5% of plan assets
Three-year filing history
How the reported figures changed
Each chart uses the selected public filing for that year. Missing values remain blank rather than becoming zero.
2025
Not reported
2025
$7
2025
31
2025
$231,466
2025
0.5%
| Plan year | Employer money per active participant | Active participants | Plan assets |
|---|---|---|---|
| 2025 | Not reported | 31 | 231.5K |
Changes in plan assets are not the same as investment performance.
Plan health
Operational signals worth checking
- Participant loans as a share of plan assets
- 0.5%
- Independent accountant’s opinion
- Not stated in the filing
- Late participant contributions reported
- Not reportedA “yes” needs context and is not, by itself, proof of wrongdoing.
- Loan defaults reported
- Not reported
- Lease defaults reported
- Not reportedOnly a small number of filings report these events.
- Nonexempt transactions reported
- Not reported
- Public plan identifier
- 900543583-001
Reported plan details
Identity and filing status
- Plan type
- Retirement plan
- Employer arrangement
- 1
- Plan effective date
- Jan 1, 2015
- Industry
- Professional, scientific, and technical services
- Amended filing
- No
- Final filing for this plan
- No
- Short plan year
- No
- 401(k) feature reported
- Yes
Show DOL characteristic codes
2E2F2G2J2K2T3D3H
Company filings
What the company has told the SEC about this plan
We found these passages in official company filings. They may help explain the plan, but we do not treat them as current benefits until the wording and date have been checked.
10-K · report period Dec 31, 2025GENESIS ENERGY LP — 10-K filed 2026-02-18 ↗
Official filing · details not yet checkedWhat it says about vesting
on a change in control (as defined in our 2018 LTIP), the unvested service tranche of the outstanding LTIP cash awards granted in April 2025, April 2024 and April 2023 will become fully vested and the unvested performance tranche of such cash awards will vest at 200% of the performance metric. Based on a hypothetical change in control on December 31, 2025, the change of control benefits for Messrs. Grant E. Sims, Ryan S. Sims, Gaspard, and Alexander, and Ms. Jesulaitis would have been as follows: Grant E. Sims Ryan S. Sims Kristen O. Jesulaitis Garland G. Gaspard Richard R. Alexander Cash payment for vested awards under 2018 LTIP granted in 2025 $ 7,200,000 $ 3,600,000 $ 3,150,000 $ 1,350,000 $ 1,500,000 Cash payment for vested awards under 2018 LTIP granted in 2024 7,200,000 3,440,000 3,0
What it says about fees
ereas no impairment expense was reported in 2025 (see “Results of Operations” below for additional details). These impacts were partially offset by: (i) an increase in general and administrative expenses of $28.0 million primarily related to an increase in third-party transaction costs incurred associated with the sale of the Alkali Business on February 28, 2025; (see “Results of Operations” below for additional details); (ii) an increase in depreciation and amortization expense of $25.4 million (see “Results of Operations” below for additional details); and (iii) a decrease in equity in earnings of equity investees of $10.7 million. We reported Net Loss from Discontinued Operations, net of tax of $423.7 million in 2025 and Net Income from Discontinued Operations, net of tax of $17.8 milli
Current plan terms
Help fill the gap the filing leaves.
If you have a current SPD, fee disclosure, or enrollment guide, you can share it with us. We check the source and date before adding anything to the profile.
Filing evidence
Open the selected public records
We use the latest valid received filing for each year after resolving amendments and duplicate records. Open the source to check the original filing.
Filing ACK_ID20260628130043NAL0009616659001
Data sourceDOL Form 5500 bulk data ↗
Filing searchEFAST2 ↗